The average one-year price target for Alumis (NasdaqGS:ALMS) has been revised to $40.35 / share. This is an increase of 11.20% from the prior estimate of $36.28 dated February 21, 2026.
The price target is an average of many targets provided by analysts. The latest targets range from a low of $32.32 to a high of $52.50 / share. The average price target represents an increase of 53.29% from the latest reported closing price of $26.32 / share.
What is the Fund Sentiment?
There are 150 funds or institutions reporting positions in Alumis. This is an decrease of 93 owner(s) or 38.27% in the last quarter. Average portfolio weight of all funds dedicated to ALMS is 0.90%, an increase of 160.86%. Total shares owned by institutions decreased in the last three months by 8.87% to 74,415K shares. 
The put/call ratio of ALMS is 0.39, indicating a bullish outlook.
What are Other Shareholders Doing?
AyurMaya Capital Management Company holds 15,140K shares representing 12.29% ownership of the company. No change in the last quarter.
Foresite Capital Management V holds 5,779K shares representing 4.69% ownership of the company. No change in the last quarter.
Samsara BioCapital holds 5,757K shares representing 4.68% ownership of the company. In its prior filing, the firm reported owning 4,801K shares , representing an increase of 16.60%. The firm increased its portfolio allocation in ALMS by 131.77% over the last quarter.
venBio Partners holds 4,620K shares representing 3.75% ownership of the company. No change in the last quarter.
Foresite Capital Management VI holds 4,248K shares representing 3.45% ownership of the company. No change in the last quarter.
Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.
Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.
This story originally appeared on Fintel.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
